The CMIT Radiopharmaceutical Sciences team is focused on developing new radiopharmaceuticals through its innovative research. The team is also engaged in the production of routine radiopharmaceuticals for in-house use and commercial distribution. Radiopharmaceutical production and distribution is performed by Southern Isotopes, an arm of CMIT, from facilities located in Shreveport and Baton Rouge, LA. Southern Isotopes specializes in GMP-compliant radiopharmaceutical manufacturing and provides multiple products under approved ANDA and IND applications.
The PET Imaging Center offers PET/CT imaging and radionuclidic therapies. The PET/CT procedures offered by CMIT are for a variety of oncology, neurology and cardiology indications using multiple in-house available radiopharmaceuticals. The PET Center is also engaged in several clinical trials in areas such as Alzheimer’s disease, prostate cancer, breast cancer, and rheumatoid arthritis.